Synapse - Works

Results (5608)

A prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging

Meeting Abstract

Durack, J. C.; Alva, A. S.; Preston, M. A.; Pouliot, F.; Saperstein, L.; Carroll, P. R.; Pienta, K. J.; Rowe, S. P.; Patnaik, A.; Probst, S.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer

Meeting Abstract

De Jesus Escano, M. R.; Sjoberg, D. D.; McCarter, M.; McGill, M.; Goh, A.; Donahue, T. F.; Donat, M. S.; Cha, E. K.; Herr, H. W.; Meraney, A. M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort

Meeting Abstract

Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Jones, D. R.; Bains, M. S.; Bajorin, D. F.; Bosl, G. J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer

Meeting Abstract

Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Evaluating the role of stereotactic body radiation therapy with respect to androgen receptor signaling inhibitors for metastatic prostate cancer

Meeting Abstract

Brennan, V.; Spektor, A.; Sweeney, C.; Choudhury, A. D.; Rathkopf, D. E.; Pomerantz, M.; Hertan, L. M.; Martin, N. E.; Nguyen, P. L.; Balboni, T. A.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma

Meeting Abstract

Carlo, M. I.; Attalla, K.; Patil, S.; Murray, S. J.; Chen, Y. B.; Kotecha, R.; Durack, J. C.; Motzer, R. J.; Hakimi, A. A.; Voss, M. H.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Patient-reported outcomes of patients with advanced renal cell carcinoma (aRCC) treated with first-line nivolumab plus cabozantinib versus sunitinib: The CheckMate 9ER trial

Meeting Abstract

Cella, D.; Choueiri, T. K.; Blum, S. I.; Ejzykowicz, F.; Hamilton, M.; Zhang, J.; Ivanescu, C.; Motzer, R. J.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

EV-201 Cohort 2: Enfortumab vedotin in cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer who received prior PD-1/PD-L1 inhibitors

Meeting Abstract

Balar, A. V.; McGregor, B. A.; Rosenberg, J. E.; van der Heijden, M. S.; Park, S. H.; Lee, J. L.; Harrison, M. R.; Heath, E. I.; Stein, M. N.; Loriot, Y.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC)

Meeting Abstract

Bajorin, D. F.; Witjes, J. A.; Gschwend, J.; Schenker, M.; Valderrama, B. P.; Tomita, Y.; Bamias, A.; Lebret, T.; Shariat, S.; Park, S. H.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Pembrolizumab for the treatment of patients with high-risk (HR) non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin: Extended follow-up of KEYNOTE-057 cohort A

Meeting Abstract

Balar, A. V.; Kamat, A. M.; Kulkarni, G. S.; Uchio, E. M.; Boormans, J. L.; Roumiguie, M.; Krieger, L. E. M.; Singer, E. A.; Bajorin, D. F.; Grivas, P.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save